Pittsburgh, Pennsylvania 15232

  • Breast Cancer Female


Hormone responsive breast cancer is common and costly. Long-term adjuvant endocrine therapy (AET) improves breast cancer outcomes greatly, but, unfortunately, is commonly associated with physical and emotional concerns. I propose to evaluate the feasibility and preliminary effectiveness of a behavioral intervention to facilitate problem identification, provide education, coaching for breast cancer survivors with symptoms while on AET. Therefore, the intervention intends to empower women to engage in better self-care and seek out resources they need, which, in turn, will lead to better symptom management.


Inclusion Criteria: - Age ≥ 50. - Nonmetastatic bread cancer survivors reporting being bothered by 1 or more symptoms related to their treatment with AET (for > 0 months and < 6 months). - Possess a household or cell telephone. - Ability to provide informed consent. Exclusion Criteria: - Clinically significant cognitive impairment. - Communication barrier limiting ability to participate in telephone assessments.



Primary Contact:

Principal Investigator
G van Londen, MD, MS
University of Pittsburgh

Backup Contact:


Location Contact:

Pittsburgh, Pennsylvania 15232
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: June 16, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.